These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2193018)

  • 21. The unrelated bone marrow donor.
    van Rood JJ; Zwaan FE; Willemze R
    Bone Marrow Transplant; 1988 Sep; 3(5):371-7. PubMed ID: 3142631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow transplantation for leukemia utilizing HLA-matched unrelated donors.
    Champlin R
    Bone Marrow Transplant; 1993; 11 Suppl 1():74-7. PubMed ID: 8448555
    [No Abstract]   [Full Text] [Related]  

  • 23. [Transplantation immunology in allogeneic bone marrow transplantation. The significance of HLA-tissue crossmatching between donors and recipients].
    Egeland T; Thorsby E
    Tidsskr Nor Laegeforen; 1994 Jan; 114(3):319-22. PubMed ID: 8191429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients.
    Oudshoorn M; Cornelissen JJ; Fibbe WE; de Graeff-Meeder ER; Lie JL; Schreuder GM; Sintnicolaas K; Willemze R; Vossen JM; van Rood JJ
    Bone Marrow Transplant; 1997 Dec; 20(12):1011-7. PubMed ID: 9466272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HLA serologically mismatched unrelated bone marrow transplantation].
    Kato S
    Rinsho Ketsueki; 2006 Jul; 47(7):587-8. PubMed ID: 16910567
    [No Abstract]   [Full Text] [Related]  

  • 26. Bone marrow transplantation from unrelated volunteer donors. An overview.
    Busca A; Amoroso A; Miniero R
    Panminerva Med; 1997 Jun; 39(2):71-7. PubMed ID: 9230614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laboratory procedures used to select an unrelated HLA matched bone marrow donor.
    van Leeuwen A; Oudshoorn M; Schreuder IM; Giphart MJ; Claas FH; van Rood JJ
    Bone Marrow Transplant; 1993; 11 Suppl 1():13-6. PubMed ID: 8448537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group.
    Atkinson K; Arthur C; Bradstock K; Dale B; Downs K; Gibson J; Golenia M; Ho J; Joshua D; Juttner C
    Bone Marrow Transplant; 1995 Sep; 16(3):401-5. PubMed ID: 8535313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of unrelated bone marrow donor searches in 174 children resulting in 45 patients transplanted in the HLA-matched and -mismatched situation.
    Souillet G; Rey S; Bertrand Y; Pujol M; Pondarré C; Bourgeot JP; Raba M; Eljaafari A; Chapuis F; Manel AM; Philippe N; Gebuhrer L
    Bone Marrow Transplant; 2000 Jul; 26(1):31-43. PubMed ID: 10918403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of different histocompatibility testing methods for selection of related and unrelated bone marrow donors.
    Oudshoorn M; van Leeuwen A; van Rood JJ
    Beitr Infusionsther Transfusionsmed; 1994; 32():250-5. PubMed ID: 9422112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative donor transplants for leukemia. Scientific Advisory Committee of the International Bone Marrow Transplant Registry.
    Gale RP; Horowitz MM
    Bone Marrow Transplant; 1993; 11 Suppl 1():66-7. PubMed ID: 8448552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marrow transplants from HLA matched unrelated donors: an NMDP update and the Seattle experience.
    Anasetti C; Howe C; Petersdorf EW; Martin PJ; Hansen JA
    Bone Marrow Transplant; 1994 Jun; 13(6):693-5. PubMed ID: 7920294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Allogeneic bone marrow transplantation in children from related donors other than HLA-identical siblings].
    Morimoto T; Hattori K; Yabe H; Yabe M; Hinohara T; Shimizu T; Matsumoto M; Hagihara M; Tsuji K; Kato S
    Rinsho Ketsueki; 1998 Sep; 39(9):631-9. PubMed ID: 9796395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow donors other than HLA genotypically identical siblings for patients with thalassemia.
    Delfini C; Polchi P; Izzi T; Nicolini G; Paradisi O; Lucarelli G
    Exp Hematol; 1985 Dec; 13(11):1197-200. PubMed ID: 3905426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular techniques for typing unrelated marrow donors: potential impact of molecular typing disparity on donor selection.
    Baxter-Lowe LA
    Bone Marrow Transplant; 1994; 14 Suppl 4():S42-50. PubMed ID: 7728125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
    Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow Transplantation.
    Kolb HJ; Bender-Götze C; Holler E; Mittermüller J; Grosse-Wilde H; Wank R; Eckstein R; Scholz S; Haas RJ; Mempel W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):421-5. PubMed ID: 2480284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
    Yakoub-Agha I; Mesnil F; Kuentz M; Boiron JM; Ifrah N; Milpied N; Chehata S; Esperou H; Vernant JP; Michallet M; Buzyn A; Gratecos N; Cahn JY; Bourhis JH; Chir Z; Raffoux C; Socié G; Golmard JL; Jouet JP;
    J Clin Oncol; 2006 Dec; 24(36):5695-702. PubMed ID: 17116940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.